Senti Biosciences Inc

Research Senti Biosciences Inc (SNTI) on Bullrun: market cap USD 34.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSNTI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 34.57M
• Financial periodFY2025
• RevenueUSD 22.00K
• Net income-USD 61.44M
• Free cash flow-USD 43.64M

Valuation Snapshot

latest market cap is USD 34.57M.

About Senti Biosciences Inc

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need.

Frequently asked questions

What is Senti Biosciences Inc's market cap?

Senti Biosciences Inc's market capitalization is USD 34.57M.

What does Senti Biosciences Inc do?

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.